LTC residents have detectable antibodies 6 months after COVID vaccination
By
Alicia Lasek
Apr 12, 2021
All residents tested in University of Pittsburgh Medical Center Senior Communities were found to have antibodies against SARS-CoV-2 after full vaccination. The findings are “cautious good news,”...
This year’s new tripledemic: COVID-19, flu and RSV
By
Kristen Fischer
Jul 25, 2023
It’s going to be a pretty busy cold, flu and respiratory syncytial virus season, according to the US Centers for Disease Control and Prevention. COVID-19 is on the rise now, a year after the country...
Post-acute care after COVID-19: What to expect
By
Alicia Lasek
Apr 09, 2020
While there are many unknowns about coronavirus survivors’ future healthcare needs, a discharge model reveals what post-acute providers might soon be dealing with.
CDC’s social media toolkit tackles COVID-19 vaccination education
By
Alicia Lasek
Jan 11, 2021
LTC providers can use a new set of pre-written social media messages and digital images to encourage staff and residents to learn more about COVID-19 vaccine safety and benefits.
Vitamin D deficiency may nearly double coronavirus risk, study finds
By
Kimberly Marselas
Sep 08, 2020
Researchers determined that the relative risk of testing positive for COVID-19 was 1.77 times greater for patients with a deficiency of the vitamin compared with those who had a sufficient supply.
Laundry practices often overlooked in infection control, accreditor says
By
Alicia Lasek
Sep 09, 2020
Laundry practices deserve a bigger role in COVID-19 prevention strategies for nursing homes and senior living communities, experts warn.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
U.S., Canada ‘not that different’ in LTC staff response to pandemic work conditions: study
By
Alicia Lasek
Feb 19, 2021
“We talk about how great Canada’s healthcare system is vis-à-vis that of the United States … but we are not that different when it comes to long-term care,” the researchers say.
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
White House message on COVID-19 bivalent booster: ‘Don’t wait’
By
Kimberly Bonvissuto
Dec 12, 2022
Getting the updated bivalent COVID-19 booster is the single most important thing that older adults can do to protect their health, COVID-19 Response Coordinator Ashish Jha, MD, MPH, said during a White...